Bo Kruse - Net Worth and Insider Trading

Bo Kruse Net Worth

The estimated net worth of Bo Kruse is at least $3 Million dollars as of 2024-06-05. Bo Kruse is the EVP, CFO, SECRY & TREAS. of Y-mAbs Therapeutics Inc and owns about 210,877 shares of Y-mAbs Therapeutics Inc (YMAB) stock worth over $3 Million. Details can be seen in Bo Kruse's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bo Kruse has not made any transactions after 2024-05-31 and currently still holds the listed stock(s).

Transaction Summary of Bo Kruse

To

Bo Kruse Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bo Kruse owns 1 companies in total, including Y-mAbs Therapeutics Inc (YMAB) .

Click here to see the complete history of Bo Kruse’s form 4 insider trades.

Insider Ownership Summary of Bo Kruse

Ticker Comapny Transaction Date Type of Owner
YMAB Y-mAbs Therapeutics Inc 2024-05-31 director & EVP & CFO & Secy & Treas.

Bo Kruse Latest Holdings Summary

Bo Kruse currently owns a total of 1 stock. Bo Kruse owns 210,877 shares of Y-mAbs Therapeutics Inc (YMAB) as of May 31, 2024, with a value of $3 Million.

Latest Holdings of Bo Kruse

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
YMAB Y-mAbs Therapeutics Inc 2024-05-31 210,877 12.02 2,534,742

Holding Weightings of Bo Kruse


Bo Kruse Form 4 Trading Tracker

According to the SEC Form 4 filings, Bo Kruse has made a total of 19 transactions in Y-mAbs Therapeutics Inc (YMAB) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Y-mAbs Therapeutics Inc is the sale of 60,000 shares on May 31, 2024, which brought Bo Kruse around $723,000.

Insider Trading History of Bo Kruse

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bo Kruse Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Bo Kruse Ownership Network

Ownership Network List of Bo Kruse

No Data

Ownership Network Relation of Bo Kruse

Insider Network Chart

Bo Kruse Owned Company Details

What does Y-mAbs Therapeutics Inc do?

Who are the key executives at Y-mAbs Therapeutics Inc?

Bo Kruse is the director & EVP & CFO & Secy & Treas. of Y-mAbs Therapeutics Inc. Other key executives at Y-mAbs Therapeutics Inc include director & President and Chairman Thomas Gad , SVP and CMO Vignesh Rajah , and Senior Vice President & CCO Susan Laura Smith .

Y-mAbs Therapeutics Inc (YMAB) Insider Trades Summary

Over the past 18 months, Bo Kruse made 1 insider transaction in Y-mAbs Therapeutics Inc (YMAB) with a net sale of 60,000. Other recent insider transactions involving Y-mAbs Therapeutics Inc (YMAB) include a net purchase of 380,768 shares made by Johan Wedell-wedellsborg , a net purchase of 380,768 shares made by Biotech Aps Wg , and a net sale of 336,251 shares made by Thomas Gad .

In summary, during the past 3 months, insiders sold 92,351 shares of Y-mAbs Therapeutics Inc (YMAB) in total and bought 0 shares, with a net sale of 92,351 shares. During the past 18 months, 399,644 shares of Y-mAbs Therapeutics Inc (YMAB) were sold and 761,536 shares were bought by its insiders, resulting in a net purchase of 361,892 shares.

Y-mAbs Therapeutics Inc (YMAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Y-mAbs Therapeutics Inc Insider Transactions

No Available Data

Bo Kruse Mailing Address

Above is the net worth, insider trading, and ownership report for Bo Kruse. You might contact Bo Kruse via mailing address: C/o Y-mabs Therapeutics, Inc., 230 Park Avenue, 33rd Floor, New York Ny 10169.

Discussions on Bo Kruse

No discussions yet.